Literature DB >> 24178247

HIV/hepatitis C virus-coinfected patients and cirrhosis: how to diagnose it and what to do next?

Valérie Martel-Laferrière1, Michael Wong, Douglas T Dieterich.   

Abstract

Liver disease, specifically cirrhosis, is a leading cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients. The diagnosis of early cirrhosis in HIV/hepatitis C virus (HCV)-coinfected patients may be challenging. The development of noninvasive methods for fibrosis assessment empowers the infectious disease specialist to diagnose advanced fibrosis or cirrhosis. Early diagnosis is essential to enroll patients in screening programs for esophageal varices and hepatocellular carcinoma. Cirrhosis may also modify decisions about treatment of both HIV and HCV, including vaccination, medications chosen, and referral for liver transplant.

Entities:  

Keywords:  HIV/HCV coinfection; cirrhosis; hepatocellular carcinoma; liver failure; varices

Mesh:

Year:  2013        PMID: 24178247     DOI: 10.1093/cid/cit714

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  The forgotten component in the staging and management of HIV/hepatitis C virus-coinfected patients.

Authors:  Edward R Cachay
Journal:  Clin Infect Dis       Date:  2014-04-23       Impact factor: 9.079

2.  Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection Treatment.

Authors:  Bevin Hearn; David Delbello; Joseph Lawler; Michel Ng; Alyson Harty; Douglas T Dieterich
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-11

Review 3.  Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.

Authors:  David L Wyles; Mark S Sulkowski; Douglas Dieterich
Journal:  Clin Infect Dis       Date:  2016-07-15       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.